Tallac Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Tallac Therapeutics's estimated annual revenue is currently $2.5M per year.
- Tallac Therapeutics's estimated revenue per employee is $77,500
- Tallac Therapeutics's total funding is $83.2M.
Employee Data
- Tallac Therapeutics has 32 Employees.
- Tallac Therapeutics grew their employee count by 0% last year.
Tallac Therapeutics's People
Name | Title | Email/Phone |
---|
Tallac Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Tallac Therapeutics?
Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac's pipeline of immunotherapy candidates are derived from the company's novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a potent Toll-like receptor (TLR9) agonist (T-CpG) for targeted immune activation via systemic administration. Several TRAAC molecules are in various stages of discovery and preclinical development.
keywords:N/A$83.2M
Total Funding
32
Number of Employees
$2.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Tallac Therapeutics News
Prior to joining us, she was with Tizona Therapeutics, Inc. from July ... We assigned to Tallac Therapeutics our lease with respect to our...
Tallac Therapeutics, Inc., a Burlingame, Calif.-based biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer, raised $62m in Series A financing. Backers included venBio Partners, Morningside Venture, Lightstone Ventures, Matrix Partners China, and MRL Ven ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.9M | 32 | -29% | N/A |
#2 | $6.5M | 32 | 7% | N/A |
#3 | $3.8M | 33 | -3% | N/A |
#4 | $3.8M | 33 | 27% | N/A |
#5 | $8.7M | 33 | 14% | N/A |